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OBJECTIVES The aim of this study was to determine the effects of circumferential pulmonary vein ablation
(CPVA) and electrogram-guided ablation (EGA) on the spectral characteristics of atrial
fibrillation (AF) and the relationship between changes in dominant frequency (DF) and
clinical outcome.
BACKGROUND Circumferential pulmonary vein ablation and EGA have been used to eliminate AF. Spectral
analysis may identify high-frequency sources.
METHODS In 84 consecutive patients, CPVA (n  42) or EGA (n  42) was performed for paroxysmal
(n 49) or persistent (n 35) AF. During EGA, complex electrograms were targeted. Lead
V1 and electrograms from the left atrium and coronary sinus were analyzed to determine the
DF of AF before and after ablation.
RESULTS The left atrial DF was higher in persistent (5.83  0.86 Hz) than paroxysmal AF (5.33 
0.76 Hz, p 0.03). There was a frequency gradient from the left atrium to the coronary sinus
(p  0.02). Circumferential pulmonary vein ablation and EGA resulted in a similar decrease
in DF (18  17% vs. 17  15%, p  0.8). During a mean follow-up of 9  6 months, the
change in DF after CPVA was similar among patients with and without recurrent AF. An
acute decrease in DF after EGA was associated with freedom from recurrent AF only in
patients with persistent AF (19  14% vs. 3  6%, p  0.02).
CONCLUSIONS Both CPVA and EGA decrease the DF of AF, consistent with elimination of high-frequency
sources. Whereas the efficacy of EGA is associated with a decrease in DF in patients with
persistent AF, the efficacy of CPVA is independent of changes in DF. This suggests that
CPVA and EGA eliminate different mechanisms in the genesis of persistent AF. (J Am
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.04.053Coll Cardiol 2006;48:340–8) © 2006 by the American College of Cardiology Foundation
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un experimental studies, atrial fibrillation (AF) displays spatio-
emporal organization, reflecting high-frequency periodic
ources, such as rotors, which may be an important mechanism
f AF (1,2). In the past few years, 2 different catheter ablation
echniques, circumferential pulmonary vein ablation (3,4)
CPVA, also referred to as wide area circumferential ablation)
nd electrogram-guided ablation (EGA), both have been
eported to be efficacious in eliminating AF (5). The efficacy of
hese 2 techniques may be attributable, at least in part, to
limination of high-frequency sources. If so, this should be
eflected in changes in the spatiotemporal organization of AF.
In an attempt to gain insight into the possible mecha-
isms by which catheter ablation eliminates AF, this study
ompared the effects of CPVA and EGA on the spectral
haracteristics of AF.
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tudy subjects. The subjects of this study were 84 consec-
tive patients who underwent catheter ablation of paroxys-
al (n 49) or persistent (n 35) AF. Their mean age was
7 9 years, and 70 were men. The mean left atrial size was
3  7 mm, and the mean left ventricular ejection fraction
as 0.57  0.10. The demographic and clinical character-
stics of the patients in each group were similar except for
eft atrial diameter, which was larger in patients with
ersistent AF (Table 1).
lectrophysiologic study. Antiarrhythmic drug therapy
as discontinued at least 5 half-lives before the ablation
rocedure except in 15 patients with persistent AF who
ere being treated with amiodarone. All patients provided
ritten informed consent. Using femoral venous access, a
uadripolar electrode catheter (EP Technologies, Sunny-
ale, California) was positioned in the coronary sinus.
ranseptal catheterization was performed, and systemic
nticoagulation was initiated to maintain an activated clot-
ing time of 300 to 350 s. A temperature-controlled 8-mm
ip quadripolar catheter (Navistar, Biosense-Webster, Dia-
ond Bar, California) was advanced into the left atrium and
sed for mapping and ablation. Electrograms were displayed
t filter settings of 30 to 500 Hz (for the electrophysiologic
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July 18, 2006:340–8 Spectral Analysis of AFtudy) and were also recorded 0 to 200 Hz (for off-line spectral
nalysis). All recordings were stored on optical discs (EP-
orkmate, EPMed Systems, West Berlin, New Jersey).
adiofrequency catheter ablation. Atrial fibrillation was
nduced by rapid pacing in the coronary sinus at 10 mA,
own to a cycle length of loss of 1:1 atrial capture in 38 of
he 84 patients (45%) who presented in sinus rhythm.
ircumferential pulmonary vein ablation was performed in
2 patients in the study, as previously described (Fig. 1) (3).
he mean duration of radiofrequency energy application
as 42  11 min. If the patient still was in AF after
ompletion of this lesion set, sinus rhythm was restored by
nfusion of 1 mg of ibutilide or transthoracic cardioversion.
Electrogram-guided ablation was performed in 42 pa-
ients. The left atrium was mapped, and focal ablation was
erformed at sites of complex electrograms characterized by
short cycle (relative to the cycle length recorded within the
oronary sinus), fractionation and/or continuous electrical
ctivity (5,6). Linear ablation was not performed (Fig. 2).
he end point of EGA was termination of AF and the
nability to reinduce AF. Whenever AF terminated during
blation, reinduction was attempted by rapid atrial pacing at
cycle length of 180 to 200 ms for 10 s. Induction was
ttempted 5 times, and inducible AF was defined as AF that
asted1 min. If AF was reinduced, ablation was continued
ntil it became noninducible or until all identified complex
lectrograms were ablated. If AF still was present, sinus
hythm was restored by infusion of ibutilide or transthoracic
ardioversion. The mean duration of radiofrequency energy
pplication was 35  28 min.
After the ablation procedure, patients were monitored in
hospital bed overnight and anticoagulated with heparin.
ll patients were anticoagulated with warfarin for 3
onths after the procedure. The antiarrhythmic drug ther-
py that was used before ablation was restarted and contin-
able 1. Demographic and Clinical Characteristics
CPVA
All Patients Paroxysmal AF Persistent
42 24 18
ge (yrs) 57  10 58  10 56  1
ender (M/F) 35/7 19/5 16/2
A diameter (mm) 44  7 41  6 46  6
VEF 0.58  0.11 0.61  0.08 0.55  0
uration of AF (yrs) 7  6 7  6 6  5
ontinuous variables expressed as mean  1 SD. P1 refers to comparisons among all
atients with paroxysmal and persistent AF in the CPVA and EGA groups. For P2, c
Abbreviations and Acronyms
AF  atrial fibrillation
CPVA  circumferential pulmonary vein ablation
DF  dominant frequency
EGA  electrogram-guided ablation
FFT  fast Fourier transformationespectively. Left atrial diameter was significantly larger in patients with persistent than wi
AF atrial fibrillation; CPVA circumferential pulmonary vein ablation; EGA elected for 3 months. There were no complications in any of
he study patients.
tudy protocol. The study protocol was approved by the
nstitutional review board. Electrograms recorded at the ante-
ior base of the left atrial appendage and within the distal
oronary sinus, along with each of the 12 leads of the
lectrocardiogram (ECG), were used for signal processing.
n this study, left atrial electrograms indicate electrograms
ecorded at the base of the left atrial appendage on the
nterior left atrial wall; 1-min segments recorded during AF
efore and after ablation were analyzed. Because site-
pecific electrograms recorded in the left atrium and coro-
ary sinus may not be representative of the entire atrium,
imultaneous recordings of the 12-lead ECG also were
nalyzed. Because atrial signals are best recognized in lead
1 (7), only this lead was analyzed.
The coronary sinus catheter was kept in the same position
hroughout the procedure. The left atrial recording site was
agged on the electroanatomic mapping system to allow
ecordings at the same site before and after ablation. After
blation, left atrial electrograms were recorded only at sites
hat had not been ablated. If AF became noninducible after
blation (24 patients), then electrograms recorded during
F just before conversion were used for analysis. When AF
erminated during ablation and was noninducible (24 pa-
ients), then left atrial recordings were acquired at the site of
ast termination. When the end point of noninducibility was
ot reached, recordings of the AF before ibutilide admin-
stration or transthoracic cardioversion were used for anal-
sis. Recordings were stored on optical discs in digital
ormat for off-line analysis.
igital signal processing. Data were analyzed by fast
ourier transformation (FFT, MatLab, MathWorks, Inc.,
atick, Massachusetts). First, the QRS complex in each
ignal was subtracted from the digitized recordings as
escribed previously (8). For analysis of lead V1, QRST
ubtraction was used (Fig. 3). In each patient, the longest
T interval within the 1-min sample was used as the
uration of the subtracted signal (Fig. 3). Briefly, the
ocations of the QRST complexes were determined from a
urface ECG. Thresholds for QRS detection were set at
5% of the maximum point of the signal (upper threshold)
nd 75% of the minimum point (lower threshold). For the
EGA
P1 P2All Patients Paroxysmal AF Persistent AF
42 25 17 — 0.8
57  9 57  8 59  10 0.8 0.8
35/7 20/5 15/2 1.0 0.8
42  7 40  6 45  8 0.3 0.02
0.56  0.09 0.59  0.06 0.52  0.11 0.4 0.1
6  6 5  5 6  6 0.5 0.9
ts in the CPVA and EGA groups; P2 refers to comparisons among the 4 groups of
ous and categorical variables were compared with analysis of variance and chi-square,AF
0
.13
patien
ontinuth paroxysmal AF in both groups.
rogram-guided ablation; LA left atrium; LVEF left ventricular ejection fraction.
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Spectral Analysis of AF July 18, 2006:340–8omplex to be recognized, the signal was required to track
hrough the following series of states, in the specific order
f: 1) pass above the upper threshold; 2) pass below the
pper threshold; and then 3) pass below the lower thresh-
ld. The maximum and minimum points were defined as
he 95th and 7th percentile values of the signal histogram,
espectively. After a QRST complex was identified, a window
as set during which another QRST complex could not be
etected. In each electrogram, the longest QT was detected
nd was adjusted accordingly. The ideal QRST was deter-
ined by averaging all of the detected QRST complexes in the
lectrogram; it was then subtracted out of the electrogram
ignal in the intervals in which QRST complex detection
ccurred. After QRST subtraction using the nominal values,
he success of QRST subtraction was manually checked.
Fast Fourier transformation of the digitized bipolar
lectrograms (60,000 points) was performed to analyze the
ontent in the 0.5 to 80 Hz band. Firstly, the mean of each
ignal was subtracted in order to make the signal zero mean.
ext, a split cosine bell-tapering window was applied with
% of the data points being tapered. An estimate of the
ignal spectrum was then obtained by using a smoothed
eriodogram with a smoothing parameter of M (9). M was
etermined semiautomatically (10) using an unbiased risk
stimator method to choose the tuning parameter M in the
moothed periodogram method (9,11). The dominant fre-
uency (DF) was defined as the frequency of the highest peak
f the smoothed periodogram in the interval of 0.5 to 60 Hz.
ollow-up. All patients were seen in an outpatient clinic 3
igure 1. Circumferential pulmonary vein ablation. Shown is a posteroa
ulmonary veins (PV). Red tags indicate ablation sites. The PVs were en
sthmus and roof. LI  left inferior; LS  left superior; RI  right inferonths and then every 3 to 6 months after the ablation procedure. In addition, patients were questioned by telephone
y a nurse practitioner at bimonthly intervals and were in-
tructed to call whenever they experienced symptoms. In the
vent of symptoms suggestive of an arrhythmia, 30-day trans-
elephonic event monitors were used to document the cause of
ymptoms. The mean duration of follow-up was 9 6
onths. No patient was lost to follow-up.
One of the aims of this study was to determine the
elationship between acute changes in spectral characteris-
ics after ablation and recurrent AF during follow-up.
herefore, clinical efficacy in this study was based only on
he presence or absence of any episode of AF, asymptomatic
r symptomatic, during follow-up, not atrial flutter. Because
arly recurrences of AF after ablation may be transient (12),
blanking period of 6 weeks was employed.
tatistical analysis. Continuous variables are expressed as
ean  1 SD and were compared with Student t test. A
aired t test was used to compare the simultaneous DFs at
ifferent sites in the same patient, and also to determine the
ffect of ablation on the DF at different sites in the same
atient. Differences in groups of continuous variables were
ompared with analysis of variance. Categorical variables were
ompared by chi-square analysis or with Fisher exact test when
 10. A value of p  0.05 indicated statistical significance.
ESULTS
pectral analysis in patients with paroxysmal and persistent
F. The mean left atrial DF was significantly lower in
r projection of a 3-dimensional construction of the left atrium and the
d 1 to 2 cm from their ostia, with additional ablation lines in the mitral
S  right superior.nterioatients with paroxysmal AF, 5.4 0.7 Hz, than in patients
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July 18, 2006:340–8 Spectral Analysis of AFith persistent AF, 5.8  0.8 Hz (p  0.02). The mean
Fs recorded in the coronary sinus did not differ signif-
cantly in patients with paroxysmal and persistent AF
5.1  0.9 Hz and 5.4  0.8 Hz, respectively, p  0.2).
he DF in lead V1was 5.4  0.9 Hz in patients with
aroxysmal AF and 5.6  1.1 Hz in patients with
ersistent AF (p  0.4).
There was no significant difference in the DF of electro-
rams recorded from the left atrium (5.3  0.7 vs. 5.6 
.9, p  0.3), coronary sinus (5.1  0.8 vs. 5.4  1.0, p 
.2), or lead V1 (5.3  0.9 vs. 5.6  0.9, p  0.3) among
atients who presented in sinus rhythm (38) and had AF
nduced before ablation and who presented in spontaneous
F (46), respectively.
requency gradients. Among patients with paroxysmal
F, the mean DF was significantly greater in the left
trium, 5.3  0.7 Hz, than in the coronary sinus, 5.0  0.7
z (p  0.002), whereas the DF in lead V1 was not
ignificantly different than the DF in the left atrium (p 
.2) or the coronary sinus (p  0.2). Among patients with
ersistent AF, the mean DF in the left atrium, 5.8  0.8
z, also was greater than in the coronary sinus, 5.4  0.7
z (p  0.02). There was a trend for a higher DF in lead
1 than in the coronary sinus in patients with persistent AF
p  0.06) whereas there was no significant difference in
he DF in lead V1 and in the left atrium (p  0.7).
ffects of CPVA. In a combined analysis of patients with
aroxysmal and persistent AF, CPVA significantly de-
igure 2. Electrogram-guided ablation. Shown is a right anterior-obliqu
ngulation. Focal applications of radiofrequency energy were delivered at sit
ndicate ablation sites. Abbreviations as in Figure 1.reased the mean DF in the left atrium from 5.6  0.8 Hz Do 4.5  0.9 Hz (p  0.001) (Fig. 4). Circumferential
ulmonary vein ablation also significantly decreased the
ean DF in the coronary sinus from 5.2  0.9 Hz to 4.6 
.1 Hz (p  0.001).
Among patients with paroxysmal AF, the mean left
trial DFs before and after CPVA were 5.2  0.5 Hz and
.4  0.6 Hz, respectively (p  0.03) (Fig. 4). In the
oronary sinus, there was no significant difference in the
ean DF before, 5.1  1.0 Hz, and after CPVA, 4.8 
.0 Hz (p  0.1).
Among patients with persistent AF, the mean left atrial
F decreased significantly after CPVA from 5.9  0.9 Hz
o 4.6  1.1 Hz (p  0.003) (Fig. 4). The mean DF in the
oronary sinus also decreased significantly from 5.3  0.8
z to 4.5  1.2 Hz after CPVA (p  0.008).
ffects of EGA. In a combined analysis of patients with
aroxysmal and persistent AF, the mean left atrial DFs were
.5  0.8 Hz and 4.5  0.9 Hz before and after EGA (p 
.001) (Figs. 4 and 5). Electrogram-guided ablation also
esulted in a significant decrease in the mean DF within the
oronary sinus from 5.3  0.7 Hz to 4.6  0.9 Hz (p 
.001).
Among patients with paroxysmal AF, the mean left atrial
Fs before and after EGA were 5.4  0.8 Hz and 4.3 
.8 Hz (p  0.001) (Fig. 4). The mean DFs within the
oronary sinus were 5.1  0.7 Hz before and 4.4  0.7 Hz
fter EGA (p  0.001).
Among patients with persistent AF, the mean left atrial
jection of a 3-dimensional construction of the left atrium with caudal
t displayed complex electrograms. No linear lesions were created. Red tagse proFs before and after EGA were 5.7  0.8 Hz and 5.0 
0
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Spectral Analysis of AF July 18, 2006:340–8.9 Hz (p  0.006) (Fig. 4). The mean DFs within the
oronary sinus were 5.5  0.8 Hz before and 5.0  1.0 Hz
fter EGA (p  0.003).
ffect of ablation on spectral characteristics of lead V1.
ircumferential pulmonary vein ablation was associated
ith a significant decrease in the DF in lead V1 (5.4  0.9
s. 4.5  1.1, p  0.001) (Fig. 6). The DF in lead V1 also
as significantly lower after, 4.6  1.0 Hz, than before
GA, 5.5  1.0 (p  0.001). The magnitude of reduction
n DF in lead V1 was similar among patients with paroxys-
al and persistent AF after both CPVA (p  0.9) and
GA (p  0.5).
ifferential effects of CPVA and EGA. Circumferential
ulmonary vein ablation and EGA resulted in a similar
agnitude of reduction in DF in the left atrium (18  17%
s. 17  15%, p  0.8), in the coronary sinus (9  19% vs.
2  12%, p  0.3), and in lead V1 (17  19% vs. 14 
5%, p  0.5).
ermination of AF and DF. Atrial fibrillation terminated
igure 3. QRST subtraction. On digitized signals, QRST subtraction was
veraged QRST complex, and the blue line illustrates the averaged Q
C) Superimposed incoming electrocardiogram signal (green line) and t
lectrocardiogram signal after QRST subtraction is shown.uring ablation in 20 of the 42 patients (48%) who under- pent CPVA, and in 21 of the 42 patients (50%) who
nderwent EGA (p  0.8). Among the 49 patients with
aroxysmal AF, AF terminated during CPVA in 54% of the
4 patients and during EGA in 68% of the 25 patients (p
.4, Fisher exact test). Among the 35 patients with chronic
F, AF terminated during CPVA in 39% of the 18
atients and during EGA in 24% of the 17 patients (p 
.5, Fisher exact test). There was no significant difference
n the percent change in the DF in the left atrium (16 
3% vs. 19  18%, p  0.6), coronary sinus (11  15%
s. 10  16%, p  0.5), or lead V1 (14  15% vs. 17 
9%, p  0.5) when AF terminated during ablation and
hen it did not.
pectral characteristics and freedom from AF. During a
ean follow-up of 9  6 months, among all patients with
aroxysmal and persistent AF, 28 of the 42 patients (67%)
ho underwent CPVA and 30 of the 42 patients (71%) who
nderwent EGA were free from recurrent AF in the absence
f antiarrhythmic drug therapy after a single ablation
rmed as described in the Methods section. The green line represents an
effect (A). Incoming electrocardiogram signal is depicted in panel B.
ctrocardiogram signal after subtraction (red line) are shown. (D) Theperfo
RSTrocedure (p  0.6).
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July 18, 2006:340–8 Spectral Analysis of AFThere was no significant difference in the percent de-
rease in the DF in the left atrium (17 18% vs. 22 17%,
 0.5), coronary sinus (7  19% vs. 12  18%, p  0.4),
r lead V1 (15  18% vs. 20  21%, p  0.7) between
atients with paroxysmal or persistent AF who remained
ree from AF and patients who had recurrent AF after
PVA. There also was no significant difference in the
ercent decrease in the DF in the left atrium (19  16% vs.
3 9%, p 0.4), coronary sinus (14 12% vs. 19 11%,
 0.4), or lead V1 (16  18% vs. 13  13%, p  0.7)
etween patients with paroxysmal AF who remained free
rom AF and patients who had recurrent AF after EGA. In
ontrast, in patients with persistent AF, freedom from
ecurrent AF after EGA was associated with a greater
ercent reduction in the DF in the coronary sinus (16 
0% vs. 1  6%, p  0.002) and in lead V1 (19  14% vs.
 6%, p  0.02), but not in left atrium (18  16% vs.
 11%, p  0.28).
ISCUSSION
ain findings. This study demonstrates that: 1) the DF in
he left atrium is higher during persistent AF than during
aroxysmal AF; 2) there is a DF gradient between the left
trium and the coronary sinus during AF; 3) both CPVA
nd EGA decrease the DF of AF; 4) during mid-term
ollow-up, the efficacy of CPVA does not appear to be
elated to an acute post-ablation decrease in DF; and 5)
reedom from recurrent AF is associated with an acute
eduction in DF in the coronary sinus and lead V1 after
GA, but only in patients with persistent AF.
aroxysmal versus persistent AF. In this study, the DF in
he left atrium was higher during persistent AF than during
aroxysmal AF. This may be explained by a greater degree of
trial electroanatomical remodeling in persistent AF, resulting
n a more pronounced reduction in atrial refractoriness (13,14),
igure 4. Effect of ablation on dominant frequency. The dominant freque
nd persistent atrial fibrillation (AF) are shown before (open bars) and
lectrogram-guided ablation (EGA) (B), respectively. Similar significant r
lectrocardiogram lead V1. *p  0.05 (paired t test).nd the maintenance of drivers that have a higher DF. oConsistent with this finding, a prior experimental study
emonstrated that the left atrial DF was higher in chronic
F induced by mitral regurgitation than in pacing-induced
pisodes of acute AF (15).
F gradient from the left atrium to the coronary
inus. The DF was significantly higher in the left atrium
han in the coronary sinus during AF. A similar difference in
F was found in prior experimental studies (16–18) and in
prior clinical study (19).
The presence of a DF gradient between the left atrium
nd coronary sinus suggests that the primary drivers of AF
riginate in the left atrium and that activation of the
oronary sinus probably is mostly passive during episodes of
aroxysmal AF. It is widely accepted that the majority of the
rivers of AF and rotors do originate within the pulmonary
eins and/or left atrium (20,21).
ffect of CPVA and EGA on spectral analysis. Both
PVA and EGA resulted in a significant decrease in DF in
he left atrium and coronary sinus. However, analysis of
lectrograms recorded from 2 sites inside the left atrium and
oronary sinus may not provide detailed information on the
patial organization of AF. Spectral analysis of lead V1,
herefore, also was performed, because this lead may
eflect global activation of both atria (7). A similar effect
f CPVA and EGA was observed in lead V1, suggesting
hat the effects of ablation were not specific to the
ntracardiac recording sites but represented a global effect
n the atria.
The goal of EGA is elimination of complex electrograms
haracterized by a short cycle length, fractionation, and/or
ontinuous electrical activity (5). Sites with a short cycle
ength by definition have a higher frequency content.
ractionation and/or continuous electrical activity may be
aused by slow conduction, wave front collision, wave break,
recorded in the left atrium in all patients and in patients with paroxysmal
(solid bars) circumferential pulmonary vein ablation (CPVA) (A) and
ions in dominant frequency were also observed in the coronary sinus andncies
afterr pivot points that facilitate re-entry (6).
o
l
C
D
o
(
i
a
S
A
a
p
e
d
g
b
a
m
h
t
e
a
t
o
s
C
(
r
d
p
d
n
p
s
s
a
g
e
i
t
p
a
e
F
e
e rmati
d
346 Lemola et al. JACC Vol. 48, No. 2, 2006
Spectral Analysis of AF July 18, 2006:340–8During CPVA, the pulmonary veins are encircled with-
ut reference to the complexity of electrograms. Neverthe-
ess, CPVA also was associated with a decrease in DF.
ircumferential pulmonary vein ablation may decrease the
F by elimination of pulmonary vein tachycardias, ablation
f rotors that have anchor points near a pulmonary vein
16), debulking of the left atrium with subsequent shorten-
ng of the potential wavelengths that can propagate (22),
nd/or by ablation of ganglionated plexi (23).
pectral characteristics after ablation and clinical outcome.
n acute decrease in the DF of AF after EGA was
ssociated with a favorable clinical outcome in patients with
ersistent AF. This may suggest that ablation of complex
lectrograms resulted in elimination of triggers and/or other
riving mechanisms of AF and also possibly sites of gan-
lionated plexi. In contrast, there was no relationship
etween the acute change in DF and the clinical outcome
fter EGA for paroxysmal AF or after CPVA for paroxys-
al or persistent AF.
In patients with persistent AF, rotors that have a high DF
ave been proposed as a potential dominant mechanism of
he AF (7,13,14). Elimination of these rotors by EGA may
xplain why the efficacy of EGA was associated with an
igure 5. Effect of electrogram-guided ablation on dominant frequency (D
lectrograms before (A) and after (B) electrogram-guided ablation is show
lectrograms in both panels. As described in the text, fast Fourier transfo
ecrease in the DF after electrogram-guided ablation.cute reduction in DF. However, it should be noted that ahis study does not provide any data that prove the presence
f rotors in the human left atrium. The major finding of this
tudy is that there was an acute decrease in DF after both
PVA and EGA. Based on prior experimental studies
16,17,24), it may be inferred that elimination of rotors
esulted in the decrease in DF. However, DF also may have
ecreased due to the other mechanisms discussed in the
receding text.
The efficacy of CPVA was not associated with an acute
ecrease in DF (i.e., a reduction in DF after CPVA did not
ecessarily result in a more favorable clinical outcome). It is
ossible that not all high-frequency sources may play the
ame role in perpetuation of AF, and there may be site-
pecific differences. During EGA, all of the pulmonary veins
nd the left atrium were mapped, and all complex electro-
rams were targeted for ablation until all target sites were
liminated and/or AF became noninducible. However, dur-
ng CPVA, only those high-frequency drivers that happen
o be located along the path of encircling lesions around the
ulmonary veins are eliminated. It is possible that, in
ddition to eliminating rotors, CPVA exerts its therapeutic
ffect through other mechanisms such as atrial debulking,
representative example of fast Fourier transformation analysis of left atrial
10-s fragment of the 60-s sample was magnified to better illustrate the
on analysis was performed using samples 60-s long. There was a markedF). A
n. Autonomic denervation, and elimination of pulmonary vein
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July 18, 2006:340–8 Spectral Analysis of AFachycardias. This may explain why the efficacy of CPVA
as not associated with an acute reduction in DF.
In patients with paroxysmal AF, there was no association
etween an acute decrease in DF after CPVA or EGA and
linical outcome. During both CPVA and EGA, pulmonary
ein tachycardias are targeted. In the majority of patients
ith paroxysmal AF, ablation of pulmonary vein tachycar-
ias may be sufficient to eliminate AF. However, pulmonary
ein tachycardias may not have the highest DF and may
erve to trigger and maintain secondary drivers and/or rotors
n the atrium. It also is possible that the frequency content
f pulmonary vein tachycardias may have been underesti-
ated because recordings were made at the base of the left
trial appendage and in the coronary sinus.
In this study, only the acute effects of ablation on the
pectral characteristics of AF were analyzed. It is possible
hat progressive fibrosis and lesion maturation resulted in a
urther decrease in DF late after ablation in some patients,
hereas DFs may have increased in others due to recovery
f conduction in previously ablated sites. Therefore, an
cute reduction in DF may not necessarily be predictive of
ong-term clinical outcome.
rior studies. Spectral analysis of AF from electrocar-
iographic recordings has been reported previously by
igure 6. An example of fast Fourier transformation (FFT) analysis of lea
he 60-s sample was magnified to better illustrate the electrograms in both
RST subtraction, the electrograms are shown in red.RST cancellation techniques similar to the techniques Ased in this study, and the reproducibility of spectral
nalysis over time has been validated in patients with AF
7,25,26).
In a study that analyzed intracardiac atrial electrograms in
4 patients with AF, no association between spontaneous
ermination of AF and a decrease in DF was demonstrated.
herefore, the decreases in DF observed in this study most
ikely occurred as a result of the effects of ablation on rotors
nd were not simply a nonspecific finding associated with
onversion of AF (27).
Detailed intraoperative mapping of the atria was per-
ormed in 9 patients with chronic AF (28). Consistent with
he findings of this study, a high-frequency source that
isplayed monomorphic electrograms was identified almost
xclusively in the left atrium, whereas irregular electrograms
uggestive of fibrillatory conduction were recorded from the
est of the atria in the majority of the patients.
In a recent study, catheter ablation of AF was performed
nder the guidance of online spectral analysis to target
AF-nests” or “fibrillar myocardium,” identified by a right-
ard shift of the FFT in 34 patients with paroxysmal or
ersistent AF (29). During a mean follow-up of 10 months,
4% of patients were reported to be in sinus rhythm. It
ppears that the morphologic and spectral characteristics of
before (A) and after (B) electrogram-guided ablation. A 10-s fragment of
ls. Electrograms before QRST subtraction are shown in green. After thed V1F-nests targeted in that study are similar to the complex
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Spectral Analysis of AF July 18, 2006:340–8lectrograms targeted during EGA in this study. In another
ecent study, online spectral analysis was utilized to ablate
ites of cardiac autonomic innervation during “cardiac neu-
oablation” in patients with neurocardiogenic syncope, func-
ional atrioventricular block, or sinus node dysfunction (30).
tudy limitations. A limitation of this study is that the
pectral analysis of intracardiac electrograms was per-
ormed on electrograms recorded at only 2 intracardiac
ites and high-density analysis of the spatial organization
f AF was not feasible. However, the effects of ablation
n DF were also demonstrated with spectral analysis of
he lead V1, which may reflect global activation of the
tria (7).
A second limitation is that some of the patients with
ersistent AF were being treated with amiodarone, which
ay decrease the DF. However, in this study, each
atient served as his/her own control, and the change in
F after ablation was unlikely to be influenced by
miodarone.
This was not a randomized study. However, the patients
ere consecutive, and the clinical characteristics of patients
n both treatment groups were similar. Furthermore, each
atient served as his/her own control in the analysis of the
ffects of CPVA or EGA on DF.
onclusions. By determining the effects of CPVA and
GA on the spectral characteristics of AF, this study
rovides evidence that both CPVA and EGA results in an
cute decrease in the DFs recorded from select sites in the
eft atrium and also lead V1, suggesting that high-frequency
ources may have been eliminated. However, there is an
ssociation between an acute reduction in DF after EGA
nd clinical outcome only in patients with persistent AF,
nd the clinical efficacy of CPVA is not associated with a
eduction in the DF of AF either in patients with paroxys-
al or persistent AF. These findings suggest that different
echanisms play a role in the genesis of paroxysmal and
ersistent AF, and that CPVA and EGA exert their
herapeutic effects by different mechanisms.
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